These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28487604)

  • 1. Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis.
    Bartczak A; Zhang J; Adeyi O; Amir A; Grant D; Gorczynski R; Selzner N; Chruscinski A; Levy GA
    World J Gastroenterol; 2017 Apr; 23(15):2673-2684. PubMed ID: 28487604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Fibrinogen-Like Protein 2 Promotes Tolerance in a Fully Mismatched Murine Model of Heart Transplantation.
    Bartczak A; Chruscinski A; Mendicino M; Liu H; Zhang J; He W; Amir AZ; Nguyen A; Khattar R; Sadozai H; Lobe CG; Adeyi O; Phillips MJ; Zhang L; Gorczynski RM; Grant D; Levy GA
    Am J Transplant; 2016 Jun; 16(6):1739-50. PubMed ID: 26718313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated fibrinogen‑like protein 2 in TNBS‑induced colitis mice: Association with Th17 and regulatory T cells.
    Lin H; Chen R; Jiang X; Wu X; Huang X; Dong X; Yang X; Lin X; Chen X; Chen X; Huang Z
    Mol Med Rep; 2017 Sep; 16(3):3445-3454. PubMed ID: 28713999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
    Urbanellis P; Shyu W; Khattar R; Wang J; Zakharova A; He W; Sadozai H; Amir AZ; Shalev I; Phillips MJ; Adeyi O; Ross H; Grant D; Levy GA; Chruscinski A
    Immunology; 2015 Jan; 144(1):91-106. PubMed ID: 24990517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
    Wang J; Vuitton DA; Müller N; Hemphill A; Spiliotis M; Blagosklonov O; Grandgirard D; Leib SL; Shalev I; Levy G; Lu X; Lin R; Wen H; Gottstein B
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003755. PubMed ID: 25955764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis.
    Shalev I; Liu H; Koscik C; Bartczak A; Javadi M; Wong KM; Maknojia A; He W; Liu MF; Diao J; Winter E; Manuel J; McCarthy D; Cattral M; Gommerman J; Clark DA; Phillips MJ; Gorczynski RR; Zhang L; Downey G; Grant D; Cybulsky MI; Levy G
    J Immunol; 2008 Jan; 180(1):249-60. PubMed ID: 18097026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitis.
    Götlind YY; Raghavan S; Bland PW; Hörnquist EH
    PLoS One; 2011; 6(9):e25073. PubMed ID: 21966415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells.
    Boschetti G; Kanjarawi R; Bardel E; Collardeau-Frachon S; Duclaux-Loras R; Moro-Sibilot L; Almeras T; Flourié B; Nancey S; Kaiserlian D
    J Crohns Colitis; 2017 Jan; 11(1):105-117. PubMed ID: 27364948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A homozygous truncating mutation of FGL2 is associated with immune dysregulation.
    Janssen E; Alosaimi MF; Alazami AM; Alsuliman A; Alaiya A; Al-Saud B; Al-Mousa H; Al-Zaid TJ; Smith E; Platt CD; Alruwaili H; Albanyan S; Al-Mayouf SM; Geha RS
    J Allergy Clin Immunol; 2023 Feb; 151(2):572-578.e1. PubMed ID: 36243222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGL2 regulates IKK/NF-κB signaling in intestinal epithelial cells and lamina propria dendritic cells to attenuate dextran sulfate sodium-induced colitis.
    Li T; Chen RR; Gong HP; Wang BF; Wu XX; Chen YQ; Huang ZM
    Mol Immunol; 2020 Jan; 117():84-93. PubMed ID: 31743856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice.
    Liao G; Detre C; Berger SB; Engel P; de Waal Malefyt R; Herzog RW; Bhan AK; Terhorst C
    Gastroenterology; 2012 Mar; 142(3):582-591.e8. PubMed ID: 22155173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2.
    Liu H; Yang PS; Zhu T; Manuel J; Zhang J; He W; Shalev I; Zhang L; Cybulsky MI; Grant DR; Phillips MJ; Levy GA
    Int J Biochem Cell Biol; 2013 Feb; 45(2):408-18. PubMed ID: 23127799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
    Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
    Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
    Latha K; Yan J; Yang Y; Gressot LV; Kong LY; Manyam G; Ezhilarasan R; Wang Q; Sulman EP; Eric Davis R; Huang S; Fuller GN; Rao A; Heimberger AB; Li S; Rao G
    J Natl Cancer Inst; 2019 Mar; 111(3):292-300. PubMed ID: 29947810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
    Shalev I; Wong KM; Foerster K; Zhu Y; Chan C; Maknojia A; Zhang J; Ma XZ; Yang XC; Gao JF; Liu H; Selzner N; Clark DA; Adeyi O; Phillips MJ; Gorczynski RR; Grant D; McGilvray I; Levy G
    Hepatology; 2009 Feb; 49(2):387-97. PubMed ID: 19085958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells.
    Chan CW; Kay LS; Khadaroo RG; Chan MW; Lakatoo S; Young KJ; Zhang L; Gorczynski RM; Cattral M; Rotstein O; Levy GA
    J Immunol; 2003 Apr; 170(8):4036-44. PubMed ID: 12682232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2.
    Zhu Y; Zhou J; Feng Y; Chen L; Zhang L; Yang F; Zha H; Wang X; Han X; Shu C; Wan YY; Li QJ; Guo B; Zhu B
    Front Immunol; 2018; 9():87. PubMed ID: 29441068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.
    Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N
    Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of HIV-1 gp41 fusion peptide on CD3 antibody activated regulatory T cells].
    He LG; Hu YP; Peng H; Li MM; Liu SW; Li XJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1121-5. PubMed ID: 23127396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis.
    Hang L; Blum AM; Setiawan T; Urban JP; Stoyanoff KM; Weinstock JV
    J Immunol; 2013 Aug; 191(4):1927-34. PubMed ID: 23851695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.